Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Learn when mutual funds can be preferable to index funds, considering objectives, risk tolerance, and horizon. Make informed allocation decisions.
25,127 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Quantum computing promises a new tech frontier, but today's stock prices often reflect dreams more than cash flow. Th...
The Treasury issued a general license for energy aboard vessels, unlocking up to 140 million barrels. Markets weigh t...
BlackRock's Larry Fink presents two stark paths for oil and markets tied to the Iran conflict, challenging households...
FuboTV has faced a brutal stretch, yet new synergies from Disney and Hulu may set up a rebound in EBITDA and subscrib...
Amphastar delivered a careful Q1 2026 showing steady revenue momentum and margin discipline. This guide breaks down t...
Alphabet is tightening the gap with Nvidia as AI wins bolster its diversified business empire. Investors weigh the im...
A new warning about looming physical oil shortages is sending ripples through energy stocks. This article explains wh...
A lithium-tech startup has joined the unicorn ranks after securing major funding and a government loan, underscoring ...
The CLARITY Act cleared the Senate Banking Committee, advancing a path toward floor consideration and a broader regul...
A large fund sold about $17 million in ZoomInfo shares while the company posted slim revenue growth. This article bre...
In a higher-rate environment, CDL continues to deliver a reliable monthly cash stream with a $2.29 per-share annual d...